Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00060814
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
2003-05-14
Brief Title:
Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Pilot Study Examining the Effects of Combined Pharmacotherapy ZybanNRTBehavioral Treatment on Smoking Cessation Among MMT Patients
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this pilot study is to examine the effects of combined pharmacotherapy ZybanNRTbehavioral treatment on smoking cessation among methadone maintenance therapy patients
Detailed Description:
This is a one-arm open label pilot study of MMT patients to determine whether bupropion nicotine replacement therapy and behavioral counseling is a feasible and potentially effective intervention for smoking cessation The smoking behaviors of participants will be be followed for 6 months post quit-date to determine effect-size estimates for a future large scale trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| K01-00450-2 | None | None | None |